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LETTERAspirin Use in Patients Undergoing
Preoperative Evaluation for
Minor SurgeryTo the Editor:
We have read with great interest the article “Underutiliza-
tion of Aspirin in Patients with Advanced Colorectal Polyps”
by Fiedler et al,1 and we found it of importance with a view
to clinical prevention.
With reference to the findings reported in the article, we
would like to make the following contribution to the discus-
sion. A retrospective analysis on 3000 patients undergoing
preoperative evaluation for minor surgery was carried out in
order to evaluate aspirin intake and adherence to guidelines
for prevention of cardiovascular disease.2
We found that 505 patients were treated with aspirin
(16.8%), 312 men (61.8%) and 193 women (38.2%) (P b
.05). In the group of patients treated with aspirin we found
that 379 subjects—254 men (67%) and 125 women (33%)—
were treated with aspirin according to guidelines for preven-
tion of cardiovascular disease. In addition, 32 patients (all
men) were treated with aspirin outside of guideline indica-
tions. Seven hundred ninety-eight patients (26.6%) that
needed aspirin or antiplatelet therapy due to their cardiovascu-
lar risk were not treated, despite having no contraindication or
allergy, and 126 patients discontinued aspirin despite appro-
priate indication.
Our observation suggested that adherence to guidelines in as-
pirin indications is low in patients undergoing surgery. The oc-
currence of previous small peripheral hemorrhage is not a
contraindication for the use of antiplatelet therapy; however, in
real life we found that it is considered a limit for prescription.2,3
In a previous paper we reported that adherence to guide-
lines was higher in men compared with women.4 NowadaysFunding: None.
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garding intensity of medication use and likelihood of receiving
guideline-based drug therapy.4,5 Adherence to aspirin treat-
ment in the absence of major surgery or bleeding is an impor-
tant goal for prevention of cardiovascular disease.
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